New York Life Investment Management LLC Supernus Pharmaceuticals, Inc. Transaction History

New York Life Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$27.11 - $35.17 $37,249 - $48,323	1,374 Added 14.31%	10,979 $374,000
Q4 2023 Feb 05, 2024	SELL	$22.72 - $29.68 $5,043 - $6,588	-222 Reduced 2.26%	9,605 $277,000
Q3 2023 Nov 07, 2023	SELL	$27.57 - $32.91 $42,678 - $50,944	-1,548 Reduced 13.61%	9,827 $270,000
Q2 2023 Aug 04, 2023	SELL	$29.91 - $38.73 $50,966 - $65,995	-1,704 Reduced 13.03%	11,375 $341,000
Q1 2023 May 08, 2023	SELL	$34.93 - $42.03 $156,206 - $187,958	-4,472 Reduced 25.48%	13,079 $473,000
Q4 2022 Feb 10, 2023	BUY	$31.09 - $37.88 $58,511 - $71,290	1,882 Added 12.01%	17,551 $626,000
Q3 2022 Nov 10, 2022	BUY	$28.79 - $35.41 $35,699 - $43,908	1,240 Added 8.59%	15,669 $530,000
Q2 2022 Aug 12, 2022	BUY	$25.33 - $34.25 $365,486 - $494,193	14,429 New	14,429 $417,000

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.93B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on New York Life Investment Management LLC with notifications on news.